Page last updated: 2024-10-22

am 580 and Bright Disease

am 580 has been researched along with Bright Disease in 1 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ratnam, KK1
Feng, X1
Chuang, PY1
Verma, V1
Lu, TC1
Wang, J1
Jin, Y1
Farias, EF1
Napoli, JL1
Chen, N1
Kaufman, L1
Takano, T1
D'Agati, VD1
Klotman, PE1
He, JC1

Other Studies

1 other study available for am 580 and Bright Disease

ArticleYear
Role of the retinoic acid receptor-α in HIV-associated nephropathy.
    Kidney international, 2011, Volume: 79, Issue:6

    Topics: AIDS-Associated Nephropathy; Alcohol Oxidoreductases; Animals; Benzoates; Cell Differentiation; Cell

2011